CUBICIN Approved for S. aureus Bloodstream Infections in South Korea and Taiwan (Business Wire via Yahoo! Finance)
LEXINGTON, Mass.----Cubist Pharmaceuticals, Inc. today announced that CUBICIN received approvals in July for S. aureus bacteremia, including right-sided infective endocarditis , in both South Korea and Taiwan.

FDA sued over Provenge delay (Seattle Times)
The heated controversy over Dendreon's prostate-cancer drug Provenge has boiled over into the courtroom. A patient-advocacy group sued U...

St. Jude Medical Announces FDA Clearance Of The Proxis Embolic Protection System (Medical News Today)
St. Jude Medical, Inc., (NYSE:STJ) announced U.S. Food and Drug Administration (FDA) clearance of the 7F Proxis(TM) Embolic Protection System. [click link for full article]